FDA | Press Releases
Follow
FDA Grants Second Approval under the National Priority Voucher Pilot Program
The U.S. Food and Drug Administration today issued an approval for the lung cancer drug Hernexeos (zongertinib) as a part of the new Commissioner's National Priority Voucher (CNPV) pilot program.
